SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN)

CUSIP: 868459108

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
57,572,193
Total 13F shares
56,687,119
Share change
-496,449
Total reported value
$1,933,242,340
Put/Call ratio
73%
Price per share
$34.11
Number of holders
246
Value change
-$13,205,166
Number of buys
96
Number of sells
127

Quarterly Holders Quick Answers

What is CUSIP 868459108?
CUSIP 868459108 identifies SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) as of Q1 2024

As of 31 Mar 2024, SUPERNUS PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (SUPN) was held by 246 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,687,119 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, MACQUARIE GROUP LTD, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Polar Capital Holdings Plc, Stephens Investment Management Group LLC, LOOMIS SAYLES & CO L P, and GW&K Investment Management, LLC. This page lists 246 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.